# Safety of Wharton Jelly in Erectile Dysfunction

> **NCT02945449** · PHASE1 · COMPLETED · sponsor: **Sophia Al-Adwan** · enrollment: 9 (actual)

## Conditions studied

- Erectile Dysfunction Associated With Type 2 Diabetes Mellitus

## Interventions

- **BIOLOGICAL:** Wharton Jelly Mesenchymal stem cells

## Key facts

- **NCT ID:** NCT02945449
- **Lead sponsor:** Sophia Al-Adwan
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-04
- **Primary completion:** 2018-10-15
- **Final completion:** 2018-11
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2018-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02945449

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02945449, "Safety of Wharton Jelly in Erectile Dysfunction". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02945449. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*